12 June 2009 | Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism
| Shimomura, K; Flanagan, SE; Zadek, B; et al. |
12 March 2008 | A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.
| Tammaro, P; Flanagan, SE; Zadek, B; et al. |
27 April 2016 | Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.
| Vedovato, N; Cliff, E; Proks, P; et al. |
13 June 2018 | Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment.
| Misra, S; Vedovato, N; Cliff, E; et al. |
31 March 2016 | Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
| Babiker, T; Vedovato, N; Patel, K; et al. |
8 September 2015 | The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation.
| O'Connell, SM; Proks, P; Kramer, H; et al. |